drugset / Trial / NCT02513004

Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel

NCT02513004 ↗

Phase 4 Unknown 60 enrolled Yongjian Wu
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to test the hypothesis that the onset of the antiplatelet effect 90mg-first-dose of ticagrelor will be more rapid and greater than 300mg-loading-dose of clopidogrel evaluated by P2Y12 reaction units measured by Verify NowTM P2Y12 assay at 1 hour in patients undergoing one-stop Hybrid coronary revascularization(HCR).

Timeline

Start
2015-06
Primary completion
2017-03
Completion
2017-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg Other
Subject Ticagrelor Small molecule 90 mg Other